Autologous-derived SB cell therapy (Taipei Medical University)
自体来源的SB细胞疗法（台北医学大学）
Report date: 2022/12/31 18:10:12
Base Information
Drug NameAutologous-derived SB cell therapy (Taipei Medical University)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical University
China Registration ClassN/A
Develop Information
Active CompaniesTaipei Medical University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A